Fully funded by 
Content independently selected
Bevacizumab-bvzr could offer a cheaper alternative to the reference product.
Effects translate to poorer education, jobs, and income.
Study shows effect on weight gain, intelligence scores.
Clinicians need to recognize the variety of NIrAEs with use of ICIs and how to treat for best outcomes.
Pencil beam scanning, a highly precise form of proton therapy, seems to be very efficient at reducing radiation dose to the temporal lobe
This treatment-induced damage could contribute to the emotional dysregulation in patients with brain tumours who undergo radiotherapy
HDAC8-specific inhibitors may limit BRAF-MEK inhibition.
High-dose lapatinib is tolerable when alternating with capecitabine.
By activating the bacterial SOS response, chemotherapy treatments promote antibiotic resistance and bacterial translocation.
More than half of patients with ROS1 fusion-positive NSCLC and brain metastases respond to entrectinib
Best outcomes with highest exposure, good presurgical T-cell function.
Reductions in mortality driven by lung cancer in men, breast cancer in women.
The newly identified genetic signature can classify non-WNT/SHH medulloblastoma patients into favourable- and high-risk groups.
Updated phase II data for the novel immunotherapeutic (SL-701) show “preliminarily promising survival curve” with good tolerability
Moderate-quality evidence supports doubled prophylactic benefit.
57% intracranial clinical benefit in phase 2 trial.
Overall, the incidence of cancer was 1.5 times higher in children who had received at least one CT scan five years previously.
